{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T06:42:39Z","timestamp":1774680159438,"version":"3.50.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,7,20]],"date-time":"2020-07-20T00:00:00Z","timestamp":1595203200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Public Health"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.jiph.2020.07.008","type":"journal-article","created":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T02:59:17Z","timestamp":1598410757000},"page":"1576-1579","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Occurrence of vancomycin MIC creep in methicillin resistant isolates in Saudi Arabia"],"prefix":"10.1016","volume":"13","author":[{"given":"Sameerah","family":"Aljohani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1944-5320","authenticated-orcid":false,"given":"Laila","family":"Layqah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emad","family":"Masuadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bassam","family":"Al Alwan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Waleed","family":"Baharoon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jawaher","family":"Gramish","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salim","family":"Baharoon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"February","key":"10.1016\/j.jiph.2020.07.008_bib0005","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1476-0711-5-2","article-title":"Laboratory-based surveillance of current antimicrobial resistance patterns and trends among Staphylococcus aureus: 2005 status in the United States","volume":"5","author":"Styers","year":"2006","journal-title":"Ann Clin Microbiol Antimicrob"},{"issue":"July (1)","key":"10.1016\/j.jiph.2020.07.008_bib0010","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/jac\/40.1.135","article-title":"Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility","volume":"40","author":"Hiramatsu","year":"1997","journal-title":"J Antimicrob Chemother"},{"issue":"February (3)","key":"10.1016\/j.jiph.2020.07.008_bib0015","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1086\/381093","article-title":"Clinical features associated with bacteremia due to heterogeneous vancomycin-intermediate Staphylococcus aureus","volume":"38","author":"Charles","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"July (4)","key":"10.1016\/j.jiph.2020.07.008_bib0020","first-page":"245","article-title":"Epidemiology and clinical features of methicillin-resistant Staphylococcus aureus in the University Hospital, Jeddah, Saudi Arabia","volume":"13","author":"Madani","year":"2002","journal-title":"Can J Infect Dis"},{"issue":"December (12)","key":"10.1016\/j.jiph.2020.07.008_bib0025","first-page":"1313","article-title":"MRSA prevalence in a teaching hospital in Western Saudi Arabia","volume":"24","author":"Austin","year":"2003","journal-title":"Saudi Med J"},{"issue":"July (7)","key":"10.1016\/j.jiph.2020.07.008_bib0030","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1128\/AAC.00939-06","article-title":"Vancomycin in vitro bactericidal activity and its relationship to efficacy in clearance of methicillin-resistant Staphylococcus aureus bacteremia","volume":"51","author":"Moise","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"issue":"October (19)","key":"10.1016\/j.jiph.2020.07.008_bib0035","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1001\/archinte.166.19.2138","article-title":"High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity","volume":"166","author":"Hidayat","year":"2006","journal-title":"Arch Intern Med"},{"issue":"June (12)","key":"10.1016\/j.jiph.2020.07.008_bib0040","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1086\/421092","article-title":"Accessory gene regulator group II polymorphism in methicillin-resistant Staphylococcus aureus is predictive of failure of vancomycin therapy","volume":"38","author":"Moise-Broder","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"June (6)","key":"10.1016\/j.jiph.2020.07.008_bib0045","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1128\/JCM.42.6.2398-2402.2004","article-title":"Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia","volume":"42","author":"Sakoulas","year":"2004","journal-title":"J Clin Microbiol"},{"issue":"January (2)","key":"10.1016\/j.jiph.2020.07.008_bib0050","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1086\/524667","article-title":"Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia","volume":"46","author":"Soriano","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiph.2020.07.008_bib0055","series-title":"Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically : approved standard","author":"Ferraro","year":"2006"},{"issue":"November (11)","key":"10.1016\/j.jiph.2020.07.008_bib0060","doi-asserted-by":"crossref","first-page":"3883","DOI":"10.1128\/JCM.01388-06","article-title":"Increased vancomycin MICs for Staphylococcus aureus clinical isolates from a university hospital during a 5-year period","volume":"44","author":"Wang","year":"2006","journal-title":"J Clin Microbiol"},{"issue":"March (3)","key":"10.1016\/j.jiph.2020.07.008_bib0065","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1093\/jac\/dki486","article-title":"Decreased susceptibility to glycopeptides in methicillin-resistant Staphylococcus aureus: a 20 year study in a large French teaching hospital, 1983-2002","volume":"57","author":"Robert","year":"2006","journal-title":"J Antimicrob Chemother"},{"issue":"February (2)","key":"10.1016\/j.jiph.2020.07.008_bib0070","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1128\/AAC.00945-07","article-title":"Inhibitory activities of 11 antimicrobial agents and bactericidal activities of vancomycin and daptomycin against invasive methicillin-resistant Staphylococcus aureus isolates obtained from 1999 through 2006","volume":"52","author":"Holmes","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"issue":"October (4)","key":"10.1016\/j.jiph.2020.07.008_bib0075","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1093\/jac\/dkn246","article-title":"Vancomycin MICs did not creep in Staphylococcus aureus isolates from 2002 to 2006 in a setting with low vancomycin usage","volume":"62","author":"Alos","year":"2008","journal-title":"J Antimicrob Chemother"},{"issue":"January (Suppl 1)","key":"10.1016\/j.jiph.2020.07.008_bib0080","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1086\/491710","article-title":"Microbiological features of vancomycin in the 21st century: minimum inhibitory concentration creep, bactericidal\/static activity, and applied breakpoints to predict clinical outcomes or detect resistant strains","volume":"42","author":"Jones","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"October (4)","key":"10.1016\/j.jiph.2020.07.008_bib0085","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1093\/jac\/dkm258","article-title":"Vancomycin MIC creep in non-vancomycin-intermediate Staphylococcus aureus (VISA), vancomycin-susceptible clinical methicillin-resistant S. Aureus (MRSA) blood isolates from 2001-05","volume":"60","author":"Steinkraus","year":"2007","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"10.1016\/j.jiph.2020.07.008_bib0090","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1093\/cid\/ciq146","article-title":"Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children","volume":"52","author":"Liu","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"September (5)","key":"10.1016\/j.jiph.2020.07.008_bib0095","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1093\/cid\/ciw353","article-title":"Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society","volume":"63","author":"Kalil","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"October (10)","key":"10.1016\/j.jiph.2020.07.008_bib0100","doi-asserted-by":"crossref","first-page":"4127","DOI":"10.1128\/AAC.00616-09","article-title":"Evaluation of vancomycin and daptomycin potency trends (MIC creep) against methicillin-resistant Staphylococcus aureus isolates collected in nine U.S. Medical centers from 2002 to 2006","volume":"53","author":"Sader","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"issue":"August (3)","key":"10.1016\/j.jiph.2020.07.008_bib0105","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1093\/infdis\/jir270","article-title":"Antibiotic choice may not explain poorer outcomes in patients with Staphylococcus aureus bacteremia and high vancomycin minimum inhibitory concentrations","volume":"204","author":"Holmes","year":"2011","journal-title":"J Infect Dis"},{"issue":"July (7)","key":"10.1016\/j.jiph.2020.07.008_bib0110","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1128\/JCM.00221-09","article-title":"Accuracy of commercial and reference susceptibility testing methods for detecting vancomycin-intermediate Staphylococcus aureus","volume":"47","author":"Swenson","year":"2009","journal-title":"J Clin Microbiol"},{"issue":"December (12)","key":"10.1016\/j.jiph.2020.07.008_bib0115","doi-asserted-by":"crossref","first-page":"4528","DOI":"10.1128\/AAC.00904-08","article-title":"Vancomycin MICs for methicillin-resistant Staphylococcus aureus isolates differ based upon the susceptibility test method used","volume":"52","author":"Prakash","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"issue":"June (6)","key":"10.1016\/j.jiph.2020.07.008_bib0120","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1128\/JCM.00407-09","article-title":"Vancomycin MICs for Staphylococcus aureus vary by detection method and have subtly increased in a pediatric population since 2005","volume":"47","author":"Mason","year":"2009","journal-title":"J Clin Microbiol"},{"issue":"June","key":"10.1016\/j.jiph.2020.07.008_bib0125","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.1128\/AAC.00113-08","article-title":"Relationship between vancomycin MIC and failure among patients with methicillin-resistant Staphylococcus aureus bacteremia treated with vancomycin","volume":"52","author":"Lodise","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"issue":"April (4)","key":"10.1016\/j.jiph.2020.07.008_bib0130","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s00134-011-2130-7","article-title":"Relationship between the MIC of vancomycin and clinical outcome in patients with MRSA nosocomial pneumonia","volume":"37","author":"Choi","year":"2011","journal-title":"Intensive Care Med"},{"issue":"5","key":"10.1016\/j.jiph.2020.07.008_bib0135","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.ijantimicag.2007.07.011","article-title":"Reduced glycopeptide susceptibility in methicillin-resistant Staphylococcus aureus (MRSA)","volume":"30","author":"Appelbaum","year":"2007","journal-title":"Int J Antimicrob Agents"},{"issue":"February (2)","key":"10.1016\/j.jiph.2020.07.008_bib0140","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jinf.2009.11.011","article-title":"Vancomycin MIC creep in MRSA isolates from 1997 to 2008 in a healthcare region in Hong Kong","volume":"60","author":"Ho","year":"2010","journal-title":"J Infect"},{"issue":"July (7)","key":"10.1016\/j.jiph.2020.07.008_bib0145","doi-asserted-by":"crossref","first-page":"3162","DOI":"10.1128\/AAC.00093-09","article-title":"Nine-hospital study comparing broth microdilution and Etest method results for vancomycin and daptomycin against methicillin-resistant Staphylococcus aureus","volume":"53","author":"Sader","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"issue":"February","key":"10.1016\/j.jiph.2020.07.008_bib0150","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1093\/jac\/dkn520","article-title":"Evaluation of the Etest GRD for the detection of Staphylococcus aureus with reduced susceptibility to glycopeptides","volume":"63","author":"Leonard","year":"2009","journal-title":"J Antimicrob Chemother"},{"issue":"February","key":"10.1016\/j.jiph.2020.07.008_bib0155","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/1756-0500-6-65","article-title":"Is vancomycin MIC creep a worldwide phenomenon? Assessment of S. Aureus vancomycin MIC in a tertiary university hospital","volume":"6","author":"Joana","year":"2013","journal-title":"BMC Res Notes"},{"issue":"February (2)","key":"10.1016\/j.jiph.2020.07.008_bib0160","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.cmi.2017.06.017","article-title":"Evaluation of vancomycin MIC creep in methicillin-resistant Staphylococcus aureus infections-a systematic review and meta-analysis","volume":"24","author":"Diaz","year":"2018","journal-title":"Clin Microbiol Infect"},{"issue":"6","key":"10.1016\/j.jiph.2020.07.008_bib0165","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1590\/S0036-46652014000600002","article-title":"Evaluation of methods in detecting vancomycin MIC among MRSA isolates and the changes in accuracy related to different MIC values","volume":"56","author":"Rossatto","year":"2014","journal-title":"Rev Inst Med Trop Sao Paulo"},{"issue":"4","key":"10.1016\/j.jiph.2020.07.008_bib0170","doi-asserted-by":"crossref","first-page":"453","DOI":"10.4103\/0255-0857.103768","article-title":"Differences in vancomycin MIC among MRSA isolates by agar dilution and E test method","volume":"30","author":"Tandel","year":"2012","journal-title":"Indian J Med Microbiol"},{"issue":"February (2)","key":"10.1016\/j.jiph.2020.07.008_bib0175","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1128\/JCM.05520-11","article-title":"Is vancomycin MIC \u2018creep\u2019 method dependent? Analysis of methicillin-resistant Staphylococcus aureus susceptibility trends in blood isolates from North East Scotland from 2006 to 2010","volume":"50","author":"Edwards","year":"2012","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jiph.2020.07.008_bib0180","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3410\/M4-4","article-title":"Reduced vancomycin susceptibility among clinical Staphylococcus aureus isolates (\u2019the MIC Creep\u2019): implications for therapy","volume":"4","author":"Dhand","year":"2012","journal-title":"F1000 Med Rep"}],"container-title":["Journal of Infection and Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876034120305748?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876034120305748?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T15:09:22Z","timestamp":1761750562000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1876034120305748"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":36,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S1876034120305748"],"URL":"https:\/\/doi.org\/10.1016\/j.jiph.2020.07.008","relation":{},"ISSN":["1876-0341"],"issn-type":[{"value":"1876-0341","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Occurrence of vancomycin MIC creep in methicillin resistant isolates in Saudi Arabia","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Public Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiph.2020.07.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences.","name":"copyright","label":"Copyright"}]}}